Pacific Biosciences Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
796
- Stock Symbol
-
PACB
- Investments
-
3
- Share Price
-
$1.70
- (As of Tuesday Closing)
Pacific Biosciences General Information
Description
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Contact Information
Website
www.pacb.comCorporate Office
- 1305 O'Brien Drive
- Menlo Park, CA 94025
- United States
Corporate Office
- 1305 O'Brien Drive
- Menlo Park, CA 94025
- United States
Pacific Biosciences Timeline
Pacific Biosciences Stock Performance
As of 21-Jan-2025, Pacific Biosciences’s stock price is $1.70. Its current market cap is $500M with 294M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.70 | $1.64 | $1.16 - $7.50 | $500M | 294M | 10.1M | -$1.46 |
Pacific Biosciences Financials Summary
As of 30-Sep-2024, Pacific Biosciences has a trailing 12-month revenue of $173M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 878,448 | 2,791,392 | 1,963,538 | 4,386,550 |
| Revenue | 173,147 | 200,521 | 128,304 | 130,513 |
| EBITDA | (326,631) | (277,282) | (282,240) | (250,757) |
| Net Income | (394,240) | (306,735) | (314,248) | (181,223) |
| Total Assets | 1,450,052 | 1,746,013 | 1,767,086 | 2,006,970 |
| Total Debt | 920,752 | 933,930 | 948,481 | 955,355 |
Pacific Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pacific Biosciences Comparisons
Industry
Financing
Details
Pacific Biosciences Competitors (23)
One of Pacific Biosciences’s 23 competitors is Cytek, a Formerly VC-backed company based in Fremont, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cytek | Formerly VC-backed | Fremont, CA | ||||
| 10x Genomics | Private Equity-Backed | Pleasanton, CA | ||||
| Akoya Biosciences | Formerly VC-backed | Marlborough, MA | ||||
| Bionano Genomics | Formerly VC-backed | San Diego, CA | ||||
| Singular Genomics | Formerly VC-backed | San Diego, CA |
Pacific Biosciences Patents
Pacific Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250002960-A1 | Compositions and methods for nucleic acid extension | Pending | 26-Jun-2023 | ||
| EP-4392579-A2 | Compositions and methods for densely-packed analyte analysis | Pending | 27-Aug-2021 | ||
| US-20240318247-A1 | Compositions and methods for densley-packed analyte analysis | Pending | 27-Aug-2021 | ||
| US-20230010287-A1 | Paired-end sequencing methods and compositions | Pending | 08-Jul-2021 | ||
| EP-4367264-A1 | Paired-end sequencing methods and compositions | Inactive | 08-Jul-2021 | C12Q1/6806 |
Pacific Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pacific Biosciences Acquisitions (3)
Pacific Biosciences’s most recent deal was a Merger/Acquisition with Apton Biosystems for . The deal was made on 02-Aug-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Apton Biosystems | 02-Aug-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| Omniome | 20-Sep-2021 | Merger/Acquisition | Biotechnology | ||
| Circulomics | 20-Jul-2021 | Merger/Acquisition | Biotechnology |
Pacific Biosciences ESG
Risk Overview
Risk Rating
Updated May, 30, 2024
18.48 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,104
Rank
Percentile
Pharmaceuticals
Industry
of 851
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 60
Rank
Percentile
Pacific Biosciences FAQs
-
When was Pacific Biosciences founded?
Pacific Biosciences was founded in 2004.
-
Where is Pacific Biosciences headquartered?
Pacific Biosciences is headquartered in Menlo Park, CA.
-
What is the size of Pacific Biosciences?
Pacific Biosciences has 796 total employees.
-
What industry is Pacific Biosciences in?
Pacific Biosciences’s primary industry is Biotechnology.
-
Is Pacific Biosciences a private or public company?
Pacific Biosciences is a Public company.
-
What is Pacific Biosciences’s stock symbol?
The ticker symbol for Pacific Biosciences is PACB.
-
What is the current stock price of Pacific Biosciences?
As of 21-Jan-2025 the stock price of Pacific Biosciences is $1.70.
-
What is the current market cap of Pacific Biosciences?
The current market capitalization of Pacific Biosciences is $500M.
-
What is Pacific Biosciences’s current revenue?
The trailing twelve month revenue for Pacific Biosciences is $173M.
-
Who are Pacific Biosciences’s competitors?
Cytek, 10x Genomics, Akoya Biosciences, Bionano Genomics, and Singular Genomics are some of the 23 competitors of Pacific Biosciences.
-
What is Pacific Biosciences’s annual earnings per share (EPS)?
Pacific Biosciences’s EPS for 12 months was -$1.46.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
